Co-Authors
This is a "connection" page, showing publications co-authored by KELLY K HUNT and MEDIGET TESHOME.
Connection Strength
5.346
-
Neoadjuvant therapy in the treatment of breast cancer. Surg Oncol Clin N Am. 2014 Jul; 23(3):505-23.
Score: 0.477
-
ASO Visual Abstract: Impact of Clipped Node as a Sentinel Lymph Node on Axillary Staging Following Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer. Ann Surg Oncol. 2025 Jan; 32(1):123-124.
Score: 0.250
-
Setting the Standard for the Future of Cancer Surgery: Utilizing the Operative Standards for Trainees. J Surg Educ. 2025 Jan; 82(1):103345.
Score: 0.249
-
ASO Visual Abstract: Clinical Outcomes for Early-Stage Node-Negative HER2-Positive Breast Cancer Patients Receiving Upfront Surgery or Neoadjuvant Systemic Therapy. Ann Surg Oncol. 2024 Nov 19.
Score: 0.248
-
ASO Visual Abstract: Significance of Residual Nodal Disease in Clinically Node-Negative Breast Cancer After Neoadjuvant Chemotherapy. Ann Surg Oncol. 2024 Nov 19.
Score: 0.248
-
Significance of Residual Nodal Disease in Clinically Node-Negative Breast Cancer After Neoadjuvant Chemotherapy. Ann Surg Oncol. 2024 Oct 23.
Score: 0.247
-
Impact of Clipped Node as a Sentinel Lymph Node on Axillary Staging Following Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer. Ann Surg Oncol. 2025 Jan; 32(1):84-91.
Score: 0.247
-
ASO Author Reflections: Evolving Multidisciplinary Decision Making for Early-Stage, HER2-Positive Breast Cancer. Ann Surg Oncol. 2024 Dec; 31(13):8908-8909.
Score: 0.245
-
Clinical Outcomes in Patients with Early Stage Node-Negative HER2-Positive Breast Cancer Receiving Upfront Surgery or Neoadjuvant Systemic Therapy. Ann Surg Oncol. 2024 Dec; 31(13):8795-8801.
Score: 0.244
-
Residual Nodal Burden After Neoadjuvant Chemotherapy in cN1 Breast Cancer Patients with Positive Nodes at Targeted Axillary Dissection. Ann Surg Oncol. 2024 Oct; 31(11):7264-7270.
Score: 0.243
-
Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership: Consensus and Opportunities. Ann Surg Oncol. 2024 Oct; 31(11):7326-7334.
Score: 0.243
-
ASO Author Reflections: Management of Inflammatory Breast Cancer: No Role for Surgical De-escalation Yet. Ann Surg Oncol. 2024 Oct; 31(11):7335-7336.
Score: 0.243
-
Inflammatory Breast Cancer at the Extremes of Age. Ann Surg Oncol. 2021 Oct; 28(10):5626-5634.
Score: 0.197
-
Clinical Course of Breast Cancer Patients with Local-Regional Progression During Neoadjuvant Systemic Therapy. Ann Surg Oncol. 2021 Oct; 28(10):5477-5485.
Score: 0.197
-
Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer. Ann Surg Oncol. 2020 Dec; 27(Suppl 3):979.
Score: 0.189
-
Effectiveness and Safety of Magseed-localization for Excision of Breast Lesions: A Prospective, Phase IV Trial. Ann Surg Open. 2020 Dec; 1(2).
Score: 0.189
-
SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer. Ann Surg Oncol. 2019 Oct; 26(11):3510-3516.
Score: 0.171
-
Combining Clinical and Pathologic Staging Variables Has Prognostic Value in Predicting Local-regional Recurrence Following Neoadjuvant Chemotherapy for Breast Cancer. Ann Surg. 2017 03; 265(3):574-580.
Score: 0.145
-
Use of a Magnetic Tracer for Sentinel Lymph Node Detection in Early-Stage Breast Cancer Patients: A Meta-analysis. Ann Surg Oncol. 2016 May; 23(5):1508-14.
Score: 0.135
-
Assessing Surgeon Familiarity with the Commission on Cancer Operative Standards for Cancer Surgery. Ann Surg Oncol. 2024 Oct; 31(10):6378-6386.
Score: 0.061
-
ASO Author Reflections: The Path to Standardizing Surgical Cancer Care in the USA. Ann Surg Oncol. 2024 Oct; 31(10):6406-6407.
Score: 0.061
-
The Prevalence of Sentinel Lymph Node Positivity and Implications for the Utility of Frozen Section Diagnosis Following Neoadjuvant Systemic Therapy in Patients with Clinically Node-Negative HER2-Positive or Triple-Negative Breast Cancer. Ann Surg Oncol. 2024 Oct; 31(11):7339-7346.
Score: 0.061
-
Correction: Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6. Ann Surg Oncol. 2024 Jul; 31(7):4565.
Score: 0.060
-
Clinical Outcomes for BRCA Pathogenic Variant Carriers With Breast Cancer Undergoing Breast Conservation. JAMA Netw Open. 2024 Jun 03; 7(6):e2418486.
Score: 0.060
-
Axillary Nodal Metastases Conversion and Perioperative Complications with Neoadjuvant Pembrolizumab Therapy in Triple-Negative Breast Cancer. Ann Surg Oncol. 2024 Feb; 31(2):974-980.
Score: 0.058
-
Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6. Ann Surg Oncol. 2024 Jan; 31(1):6-9.
Score: 0.058
-
To Dissect or Not to Dissect: Can We Predict the Presence of Four or More Axillary Lymph Node Metastases in Postmenopausal Women with Clinically Node-Negative Breast Cancer? Ann Surg Oncol. 2023 Dec; 30(13):8327-8334.
Score: 0.057
-
Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection. Ann Surg Oncol. 2023 Nov; 30(12):7015-7025.
Score: 0.057
-
Operative standards for sentinel lymph node biopsy and axillary lymphadenectomy for breast cancer: review of the American College of Surgeons commission on cancer standards 5.3 and 5.4. Surgery. 2023 09; 174(3):717-721.
Score: 0.056
-
American College of Surgeons Commission on Cancer Standard 5.7 for Total Mesorectal Excision for Mid-to-Low Rectal Cancer. J Am Coll Surg. 2022 06 01; 234(6):1249-1253.
Score: 0.052
-
Impact of the early COVID-19 pandemic on Breast Surgical Oncology fellow education. J Surg Oncol. 2021 Dec; 124(7):989-994.
Score: 0.049
-
American College of Surgeons Commission on Cancer Standard for Curative-intent Pulmonary Resection. Ann Thorac Surg. 2022 01; 113(1):5-8.
Score: 0.049
-
Clinical trials-Designing, implementing, and collaborating. J Surg Oncol. 2020 Jul; 122(1):25-28.
Score: 0.045
-
Effect of Surgeon Factors on Long-Term Patient-Reported Outcomes After Breast-Conserving Therapy in Older Breast Cancer Survivors. Ann Surg Oncol. 2020 Apr; 27(4):1013-1022.
Score: 0.044
-
A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy. Ann Surg. 2018 05; 267(5):946-951.
Score: 0.039
-
Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery. JAMA Surg. 2017 07 01; 152(7):665-670.
Score: 0.037
-
Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy. Ann Surg Oncol. 2017 Mar; 24(3):652-659.
Score: 0.035